Clinical Evaluation of Fortilink® TETRAfuse® Interbody Fusion Device in Subjects With Degenerative Disc Disease

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

February 13, 2019

Primary Completion Date

June 30, 2023

Study Completion Date

December 30, 2023

Conditions
Degenerative Disc Disease
Interventions
DEVICE

Fortilink IBF System with TETRAfuse Technology

Cervical and lumbar fusion

Trial Locations (14)

14304

ReVive Spine Center, Niagara Falls

15212

Allegheny General Hospital, Pittsburgh

19107

Rothman Orthopaedic Institute, Philadelphia

20817

OrthoBethesda, Bethesda

33073

South Florida Spine & Orthopaedics, Coconut Creek

33484

Spine Institute of South Florida, Delray Beach

33496

Florida Back Institute, Boca Raton

42001

Orthopaedic Institute of Western Kentucky, Paducah

45219

The Lindner Center for Research & Education at The Christ Hospital, Cincinnati

47905

Indiana Spine Center, Indianapolis

76182

Spine MD, North Richland Hills

77382

Northwood Ortho-Spine, The Woodlands

80124

Rocky Mountain Spine Clinic, Lone Tree

91403

Los Angeles Orthopedic Institute, Sherman Oaks

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Xtant Medical

INDUSTRY

NCT03761563 - Clinical Evaluation of Fortilink® TETRAfuse® Interbody Fusion Device in Subjects With Degenerative Disc Disease | Biotech Hunter | Biotech Hunter